Transplantation Therapeutics Research: Talks about leading products and key unmet needs within the market

This leads to an anti-graft immune response that involves T cells invading the new tissue, multiplying, and recruiting more immune cells to the transplant site in order to remove this foreign body.

Pune, India - March 14, 2018 /MarketersMedia/ —

In 2015 a total of 127,000 transplantations were performed worldwide, an increase of 5.8% from 2014, with 33,000 of these occurring in the EU and 32,000 in the US. Approximately 60% of these were kidney transplants, with liver, heart, lung, pancreas and small bowel transplantations accounting for the other most common procedures (Dominguez-Gil and Matesanz, 2017). When a graft is transplanted from a genetically non-identical individual, the recipient’s immune system recognizes the graft as foreign.
Access Report Details at: https://www.themarketreports.com/report/frontier-pharma-transplantation-therapeutics-a-highly-innovative-pipeline-with-a-range-of-adaptive-and-innate-immune-targeting-programs-focusing-on-graft-versus-host-disease-and-kidney-transplantation
Reasons To Buy
• Appreciate the current clinical and commercial landscapes by considering disease symptoms, pathogenesis, etiology, co-morbidities and complications, epidemiology, diagnosis, prognosis and treatment options for transplantation rejection.
• Identify leading products and key unmet needs within the market.
• Recognize trends in pipeline innovation by analyzing therapies by stage of development, molecule type and molecular target.
• Assess the therapeutic potential of first-in-class targets. Using a proprietary molecular target matrix assessment, first-in-class targets in the pipeline have been assessed and ranked according to clinical potential.
• Consider first-in-class pipeline products with no prior involvement in licensing and co-development deals, which may represent potential investment opportunities.
Get this report at: https://www.themarketreports.com/report/buy-now/935560
Scope
• There is a need for therapies that can achieve graft-specific immunosuppression, without having a general effect on the wider immune system. Which therapies and technologies currently in development are most likely to achieve this?
• There are 63 distinct first-in-class molecular targets in development for transplantation. Which of these hold the strongest potential in the clinic, and which are closest to reaching the market?
• How effective are current therapies for these indications, and how have they been able to improve the general prognosis in recent decades?
• Which molecule types and molecular targets are most prominent across transplantation therapy?
• Which specific types of transplantation are being most heavily studied across the pharmaceutical pipeline?
Inquire for more details at: https://www.themarketreports.com/report/ask-your-query/935560

Contact Info:
Name: Shirish Gupta
Email: sales@themarketreports.com
Organization: The Market Reports
Address: SF-29, Sacred World, Wanawadi
Phone: 16314071315

Source URL: https://marketersmedia.com/transplantation-therapeutics-research-talks-about-leading-products-and-key-unmet-needs-within-the-market/314334

For more information, please visit https://www.themarketreports.com/report/frontier-pharma-transplantation-therapeutics-a-highly-innovative-pipeline-with-a-range-of-adaptive-and-innate-immune-targeting-programs-focusing-on-graft-versus-host-disease-and-kidney-transplantation%20%20

Source: MarketersMedia

Release ID: 314334

More News From Daily Xtreme

Hamilton's woes piling up after qualifying run ends early

Jul 21, 2018

HOCKENHEIM, Germany — Crouching down by the side of his Mercedes, Lewis Hamilton lowered his head and stayed perfectly still for several moments. The British driver looked lost in thought, deep in contemplation, seemingly unable to believe what happened on Saturday. A hydraulic failure had just ended his qualifying run prematurely, dropping Formula One's all-time record-holder for pole positions to 14th on the grid for Sunday's race. Hamilton's hopes of winning a record-equaling fourth German Grand Prix — and matching Michael Schumacher— have been dented. And his woes are piling up as he duels with Sebastian Vettel — in a...

Verstappen sets new lap record in second German GP practice

Jul 21, 2018

HOCKENHEIM, Germany — Max Verstappen set a new lap record in leading the second practice session for the German Grand Prix on Friday. The 20-year-old Dutch driver clocked 1 minute, 13.085 seconds to eclipse veteran Kimi Raikkonen's time of 1:13.78 from 2004. Verstappen also made it a Red Bull 1-2, after his teammate Daniel Ricciardo was best in the first practice before drifting back in the afternoon. Lewis Hamilton was second quickest in both sessions. His Mercedes teammate Valtteri Bottas finished third in the second practice, with championship leader Sebastian Vettel's Ferrari in fourth. After a rocky start to the...

Mercedes gives Valtteri Bottas 1-year contract extension

Jul 21, 2018

HOCKENHEIM, Germany — Mercedes has given Formula One driver Valtteri Bottas only moderate backing by offering him a new one-year contract. Although Bottas has the option for an extra year in 2020, the Finnish driver will have to prove he deserves it with strong performances in 2019. Mercedes announced the deal on Friday, one day after Formula One champion Lewis Hamilton agreed a two-year contract until 2020. It ends mounting speculation over the short-term future of both of its drivers. The deals were announced at the German Grand Prix with the F1 season reaching its halfway point, and with the...

Hamilton thanks Mercedes for being patient over his new deal

Jul 21, 2018

HOCKENHEIM, Germany — Formula One champion Lewis Hamilton thanked Mercedes for indulging him as he finally signed a new contract, ending months of stalling and growing speculation over his future. With his previous contract set to expire at the end of this year, the four-time world champion penned a new agreement until 2020, when the current set of F1 regulations end. No figures were given, but the bumper deal is reportedly estimated at 40 million pounds ($52 million) per year. Talks began early this year with Toto Wolff, the team's head of motorsport. Hamilton negotiates his own deals and, by...

Vettel needs to keep pressure on Hamilton in Germany

Jul 21, 2018

HOCKENHEIM, Germany — Sebastian Vettel needs to keep the pressure on Lewis Hamilton at this weekend's German Grand Prix. At the midway point of the Formula One season — the 11th of 21 races — Vettel holds an eight-point lead over Hamilton. Vettel started strongly, then Hamilton took over, and now Vettel appears to be in the ascendancy again. While he leads Hamilton only 4-3 in wins this season, Vettel's most recent victory was particularly poignant because it was at Hamilton's home track at Silverstone, where the British driver has had huge success. Vettel's win heaped more misery on Hamilton,...

NHL Livescore